Envista Holdings Corp
Profit after direct costs
Core business profitability
Bottom line profitability
Top line growth rate
Flow of revenue through cost categories to net income
| Item | Trend | 2021 | 2022 | 2023 | 2024 | 2025 | YoY Change |
|---|---|---|---|---|---|---|---|
Total Revenue | 2.51B | 2.57B | 2.57B | 2.51B | 2.72B | 8.3% | |
| Cost of Revenue | (1.05B) | (1.08B) | (1.12B) | (1.12B) | (1.22B) | 9.3% | |
Gross Profit | 1.46B | 1.49B | 1.45B | 1.39B | 1.50B | 7.5% | |
| Operating Expenses | |||||||
| Research & Development | (100.50M) | (100.10M) | (93.80M) | (99.10M) | (114.00M) | 15.0% | |
| Selling, General & Administrative | (989.50M) | (1.03B) | (1.03B) | (1.14B) | (1.16B) | 1.8% | |
| Depreciation & Amortization | (123.60M) | (137.80M) | (135.60M) | (123.10M) | (116.00M) | -5.8% | |
Operating Income (EBIT) | 306.20M | 319.20M | 31.50M | -1.04B | 225.70M | -121.7% | |
| Non-Operating Items | |||||||
| Interest Income | — | — | — | — | — | — | |
| Interest Expense | (54.10M) | (38.40M) | (63.40M) | (46.40M) | (36.60M) | -21.1% | |
| Other Income/Expenses (Net) | -51.70M | -35.30M | -86.40M | -46.50M | -48.50M | 4.3% | |
Income Before Tax | 254.50M | 283.90M | -54.90M | -1.08B | 177.20M | -116.3% | |
| Income Tax Expense | (9.00M) | (45.90M) | (45.30M) | (33.90M) | (130.20M) | 284.1% | |
Net Income | 340.50M | 243.10M | -100.20M | -1.12B | 47.00M | -104.2% | |
| Per Share Metrics | |||||||
| Earnings Per Share (Basic) | $2 | $1 | $-1 | $-7 | $0 | -104.3% | |
| Weighted Avg Shares Outstanding | 161.20M | 162.90M | 166.90M | 172.20M | 168.00M | -2.4% | |
| Weighted Avg Shares Outstanding (Diluted) | 177.60M | 177.60M | 166.90M | 172.20M | 169.20M | -1.7% | |
EBITDA | 496.00M | 497.70M | 463.00M | 279.50M | 329.80M | 18.0% |
Explore NVST
NVST in the Healthcare
Mid Cap